Generics - Production

Filter

Current filters:

Production

Popular Filters

1 to 25 of 108 results

With buy of Veropharm, Abbott to significantly increase revenue in Russia

With buy of Veropharm, Abbott to significantly increase revenue in Russia

17-12-2014

US drugmaker Abbott plans to significantly increase its revenue in the Russian market over the next several…

AbbottFinancialGenericsMarkets & MarketingProductionRussiaVeropharm

Ranbaxy may establish production in Russia

Ranbaxy may establish production in Russia

16-12-2014

Generic pharma company Ranbaxy, one of India’s largest drugmakers which is in the process of being…

Antibiotics and Infectious diseasesGenericsNeurologicalProductionRanbaxyRussia

AbbVie acquires API facility in Singapore; Amgen completes new unit

AbbVie acquires API facility in Singapore; Amgen completes new unit

26-11-2014

US pharma major AbbVie has acquired a small-molecule active pharmaceutical ingredient (API) manufacturing…

AbbVieAmgenBiotechnologyGenericsProductionSingapore

China pharma excipients market to reach $8.9 billion in 2017

China pharma excipients market to reach $8.9 billion in 2017

24-11-2014

Currently, pharmaceutical excipients account for about 2%-3% of China's total output value of pharmaceutical…

ChinaGenericsMarkets & MarketingProduction

Beximco Pharma receives GMP approval from Health Canada

Beximco Pharma receives GMP approval from Health Canada

24-11-2014

Bangladeshi drugmaker Beximco Pharma has received Good Manufacturing Practices approval from Health Canada,…

BangladeshBeximco PharmaceuticalsCanadaGenericsProductionRegulation

FDA consent decree with Ascend Labs backed by federal judge

FDA consent decree with Ascend Labs backed by federal judge

15-10-2014

A federal judge from the US District Court for the Southern District of Ohio entered a consent decree…

Ascend LaboratoriesGenericsLegalProductionRegulationUSA

Intrexon and Amneal in second product collaboration

Intrexon and Amneal in second product collaboration

02-10-2014

US synthetic biology specialist Intrexon and privately-held generics drugmaker Amneal Pharmaceuticals…

Amneal PharmaceuticalsGenericsIntrexonLicensingProductionUSA

Hospira warned by FDA over Australian manufacturing facility

Hospira warned by FDA over Australian manufacturing facility

02-10-2014

USA-based injectable generic drugs specialist Hospira revealed in a filing with the US Securities and…

AustraliaGenericsHospiraProductionRegulationUSA

Indian industry decries smear campaign against its pharma exporters

Indian industry decries smear campaign against its pharma exporters

26-09-2014

The India Brand Equity Foundation (IBEF), on behalf of the government of India, has taken strong objection…

Antibiotics and Infectious diseasesGenericsIndiaMarkets & MarketingPoliticsProductionUSA

Alchem International commits to tropane alkaloid APIs to resolve supply gap

15-09-2014

Following the decision by the principal European manufacturers to exit or end market development and…

Alchem InternationalGenericsIndiaMarkets & MarketingProductiontropane alkaloid

Amerigen Pharma and Ningbo Menovo link up on generics for US market

27-08-2014

US generic drugmaker Amerigen Pharmaceuticals and China’s Ningbo Menovo Pharmaceutical have entered…

Amerigen PharmaceuticalsChinaGenericsNingbo MenovoProductionResearchUSA

EMS Group inaugurates NovaMed/EMS, Manaus' first pharmaceutical factory

EMS Group inaugurates NovaMed/EMS, Manaus' first pharmaceutical factory

27-08-2014

Brazilian Minister of Health Arthur Chioro participated in the inauguration ceremony of NovaMed/EMS,…

BrazilEMS GroupFinancialGenericsNovaMedProduction

Generics production predicted to return to the USA due to quality concerns

Generics production predicted to return to the USA due to quality concerns

08-08-2014

Generics production represents a huge area of growth for the US market, which is partially driven by…

Business FinanceCPhI Pharma Insights USAGenericsProductionUSA

Indian generic drugmakers set to score from MPP deals on HIV drugs

Indian generic drugmakers set to score from MPP deals on HIV drugs

28-07-2014

Seven new sub-licensing agreements for the manufacture of generic HIV medicines and two new generation…

Anti-viralsGenericsIndiaLicensingPatentsProduction

Medicines Patent Pool broadens collaboration with Gilead Sciences

24-07-2014

The Medicines Patent Pool (MPP) has entered into a new licensing agreement with US biotech firm Gilead…

Anti-viralsChinaGenericsGilead SciencesIndiaLicensingProductiontenofovir alafenamide

Hikma to take over Boehringer’s Ben Venue manufacturing site

24-07-2014

Jordan-based drugmaker Hikma Pharmaceuticals says it has agreed with Ben Venue Laboratories, part of…

Ben Venue LabsBoehringer IngelheimGenericsHikma PharmaceuticalsMergers & AcquisitionsProductionUSA

Glenmark Pharma to set up new manufacturing facility in USA

Glenmark Pharma to set up new manufacturing facility in USA

17-07-2014

Indian drugmaker Glenmark Pharmaceuticals plans to set up a new manufacturing facility at Monroe Corporate…

GenericsGlenmark PharmaceuticalsProductionUSA

Sun Pharma acquires Pharmalucence

Sun Pharma acquires Pharmalucence

16-07-2014

Sun Pharmaceutical Industries, India's third-largest generic drugmaker by sales, revealed that it has…

BSE SensexEconomy of IndiaGenericsIndiaMergers & AcquisitionsPharmalucenceProductionRanbaxy LaboratoriesSun Pharmaceuticals

US regulatory warnings on drug producers extend well beyond India

US regulatory warnings on drug producers extend well beyond India

14-07-2014

Hauled up by the US Food and Drug Administration for product recalls and quality issues, Indian pharmaceutical…

CiplaDr Reddy's LaboratoriesGenericsIndiaLupinProductionRanbaxy LaboratoriesRegulationSun PharmaceuticalUSA

Hospira completes buy of Orchid's API production and R&D facility

Hospira completes buy of Orchid's API production and R&D facility

06-07-2014

US provider of injectable drugs and infusion technologies Hospira says it has completed the acquisition…

GenericsHospiraIndiaMergers & AcquisitionsOrchid Chemicals & PharmaceuticalsProduction

Esteve to launch new generic version of omeprazole

Esteve to launch new generic version of omeprazole

18-06-2014

Pensa Pharma, subsidiary of Spanish pharmaceutical company Grupo Esteve, has launched a new formulation…

Esteve GroupGastro-intestinalsGenericsOmeprazoleProductionSpain

Ranbaxy’s Toansa plant assessment concluded: no risk to public health, EU view

Ranbaxy’s Toansa plant assessment concluded: no risk to public health, EU view

05-06-2014

European regulatory authorities have finalized their assessment of reported non-compliance with Good…

EuropeGenericsIndiaProductionRanbaxy LaboratoriesRegulation

AMRI to buy Oso Biopharmaceuticals Manufacturing for $110 million

AMRI to buy Oso Biopharmaceuticals Manufacturing for $110 million

02-06-2014

USA-based Albany Molecular Research has signed a definitive agreement to acquire all of the outstanding…

Albany Molecular ResearchGenericsMergers & AcquisitionsOso BiopharmaceuticalsProduction

1 to 25 of 108 results

Back to top